AAV2-hRPE65v2 vector
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AAV2-hRPE65v2 vector, covering 2025-04-29 to 2025-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Follow-on Study of AAV2-hRPE65v2 Vector in Subjects With Leber Congenital Amaurosis (LCA) 2 [Phase 1, Phase 2]